Molecular species of epidermal growth factor carrying immunosuppressive activity.
The suppression of antibody formation to sheep red cells in mice by partially purified fractions of mouse submaxillary gland was shown to be caused by epidermal growth factor (EGF). Purification of EGF by the method of Savage and Cohen resolved three components referred to as EGF a, EGF b, and EGF c. All three induced premature eye opening in neonatal mice, but only EGF a (identified as EGF 1-53) had full immunosuppressive activity. EGF c was shown by micropeptide mapping of chymotryptic and thermolytic digests and amino-terminal analysis to differ from EGF a only by the presence of beta-aspartyl instead of an asparaginyl residue. EGF b differed from EGF a in that it lacked the N-terminal asparagine. EGF shortened enzymatically at its carboxy terminal by two or five amino acids did not have any immunosuppressive activity. These findings suggest that, in contrast to some other biological effects of EGF, intact amino and carboxy terminals are required for the expression of immunosuppressive activity.
D000818:Animals; D004815:Epidermal Growth Factor / Q000032:analysis / Q000494:pharmacology*; D007108:Immune Tolerance / Q000187:drug effects*; D046911:Macromolecular Substances; D008297:Male; D051379:Mice; D010446:Peptide Fragments / Q000032:analysis; D011487:Protein Conformation; D013329:Structure-Activity Relationship
D046911:Macromolecular Substances; D010446:Peptide Fragments; D004815:Epidermal Growth Factor